Journal of Antimicrobial Chemotherapy (1990) 25, 199-208
© 1990 The British Society for Antimicrobial Chemotherapy
research-article |
Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I ß-lactamases
Department of Medical Microbiology, The London Hospital Medical College Turner Street, London E1 2AD, UK
Received 10 August 1989; accepted 14 September 1989
*Corresponding author
Clavulanate and tazobactam (YTR 830) were tested as inhibitors and inducers of the AmpC-type Class I ß-lactamases of Pseudomonas aeruginosa, Enterobacter cloacae, Citrobacter freundii, Serratia marcescens, Morganella morganii and the Ic ßlactamase of Proteus vulgaris. Both clavulanate and tazobactam inhibited the Pr. vulgaris Class Ic ßlactamase and potentiated ticarcillin and piperacillin against ß-lactamase derepressed variants of this species. Tazobactam, but not clavulanate, also had some ability to inhibit the AmpC Class I enzymes of M. morganii, C. freundii, Ps. aeruginosa, E. cloacae and S. marcescens. The piperacillin + tazobactam combination, unlike ticarcillin + clavulanate, showed some degree of synergy against most derepressed strains of these species. This behaviour partly depended upon the greater inhibitory activity of tazobactam for the enzymes, but also on piperacillin being easier to potentiate than ticarcillin. The synergy between piperacillin and tazobactam was greatest for M. morganii and C. freundii, least for Ps. aeruginosa and E. cloacae. Unfortunately, it is in the last two species that these enzymes pose the greatest resistance threat Tazobactam caused little or no antagonism of piperacillin against ß-lactamase inducible species, whereas clavulanate antagonized ticarcillin against ß-lactamase inducible strains of E. cloacae and M. morganii (not other species). The antagonism of ticarcillin was attributable to ß-lactamase induction. The lack of antagonism with the tazobactam + piperacillin combination was related to tazobactam being a weaker inducer than clavulanate, not to piperacillin being less susceptible to antagonism than ticarcillin.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Marcos, A. Inurrieta, A. Soriano, J. A. Martinez, M. Almela, F. Marco, and J. Mensa Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia J. Antimicrob. Chemother., August 1, 2008; 62(2): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mushtaq, M. Warner, Y. Ge, K. Kaniga, and D. M. Livermore In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes J. Antimicrob. Chemother., August 1, 2007; 60(2): 300 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Power, M. Galleni, J. A. Ayala, and G. Gutkind Biochemical and Molecular Characterization of Three New Variants of AmpC {beta}-Lactamases from Morganella morganii Antimicrob. Agents Chemother., March 1, 2006; 50(3): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Dunne Jr. and D. J. Hardin Use of Several Inducer and Substrate Antibiotic Combinations in a Disk Approximation Assay Format To Screen for AmpC Induction in Patient Isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp. J. Clin. Microbiol., December 1, 2005; 43(12): 5945 - 5949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. T. Stearne, D. van Boxtel, N. Lemmens, W. H. F. Goessens, J. W. Mouton, and I. C. Gyssens Comparative Study of the Effects of Ceftizoxime, Piperacillin, and Piperacillin-Tazobactam Concentrations on Antibacterial Activity and Selection of Antibiotic-Resistant Mutants of Enterobacter cloacae and Bacteroides fragilis In Vitro and In Vivo in Mixed-Infection Abscesses Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1688 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Girlich, T. Naas, S. Bellais, L. Poirel, A. Karim, and P. Nordmann Biochemical-Genetic Characterization and Regulation of Expression of an ACC-1-Like Chromosome-Borne Cephalosporinase from Hafnia alvei Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1470 - 1478. [Abstract] [Full Text]
|
|
|
|
|
|
L. Poirel, M. Guibert, D. Girlich, T. Naas, and P. Nordmann Cloning, Sequence Analyses, Expression, and Distribution of ampC-ampR from Morganella morganii Clinical Isolates Antimicrob. Agents Chemother., April 1, 1999; 43(4): 769 - 776. [Abstract] [Full Text]
|
|
|
|
|
|
P. D. Lister, V. M. Gardner, and C. C. Sanders Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin Antimicrob. Agents Chemother., April 1, 1999; 43(4): 882 - 889. [Abstract] [Full Text]
|
|
|
|
|
|
P. D. Lister, W. E. Sanders Jr., and C. C. Sanders Cefepime-Aztreonam: a Unique Double beta -Lactam Combination for Pseudomonas aeruginosa Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1610 - 1619. [Abstract] [Full Text]
|
|